China Central Nervous System Disorders Therapeutics Market Report & Forecast 2021-2027

Publisher Name :
Date: 22-Dec-2021
No. of pages: 93
Inquire Before Buying

China Central Nervous System Disorders Therapeutics Market, By Type, 2016-2021, 2022-2027 ($ Millions)

China Central Nervous System Disorders Therapeutics Market Segment Percentages, By Type, 2020 (%)

- Depression

- MS

- bipolar disorder

- schizophrenia

- epilepsy

- AD

- Parkinson' s

- others

China Central Nervous System Disorders Therapeutics Market, By Application, 2016-2021, 2022-2027 ($ Millions)

China Central Nervous System Disorders Therapeutics Market Segment Percentages, By Application, 2020 (%)

- Clinicals

- Hospitials

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Central Nervous System Disorders Therapeutics revenues in China market, 2016-2021 (Estimated), ($ millions)

Key companies Central Nervous System Disorders Therapeutics revenues share in China market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

- Eli Lilly

- GlaxoSmithKline

- Janssen Pharmaceuticals

- Novartis

- Pfizer

China Central Nervous System Disorders Therapeutics Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Central Nervous System Disorders Therapeutics Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Central Nervous System Disorders Therapeutics Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 China Central Nervous System Disorders Therapeutics Overall Market Size
2.1 China Central Nervous System Disorders Therapeutics Market Size: 2021 VS 2027
2.2 China Central Nervous System Disorders Therapeutics Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Central Nervous System Disorders Therapeutics Players in China Market
3.2 Top China Central Nervous System Disorders Therapeutics Companies Ranked by Revenue
3.3 China Central Nervous System Disorders Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Central Nervous System Disorders Therapeutics Companies in China Market, by Revenue in 2020
3.5 Companies Central Nervous System Disorders Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Central Nervous System Disorders Therapeutics Players in China Market
3.6.1 List of Tier 1 Central Nervous System Disorders Therapeutics Companies in China
3.6.2 List of Tier 2 and Tier 3 Central Nervous System Disorders Therapeutics Companies in China
4 Sights by Type
4.1 Overview
4.1.1 By Type - China Central Nervous System Disorders Therapeutics Market Size Markets, 2021 & 2027
4.1.2 Depression
4.1.3 MS
4.1.4 bipolar disorder
4.1.5 schizophrenia
4.1.6 epilepsy
4.1.7 AD
4.1.8 Parkinson' s
4.1.9 others
4.2 By Type - China Central Nervous System Disorders Therapeutics Revenue & Forecasts
4.2.1 By Type - China Central Nervous System Disorders Therapeutics Revenue, 2016-2021
4.2.2 By Type - China Central Nervous System Disorders Therapeutics Revenue, 2022-2027
4.2.3 By Type - China Central Nervous System Disorders Therapeutics Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - China Central Nervous System Disorders Therapeutics Market Size, 2021 & 2027
5.1.2 Clinicals
5.1.3 Hospitials
5.2 By Application - China Central Nervous System Disorders Therapeutics Revenue & Forecasts
5.2.1 By Application - China Central Nervous System Disorders Therapeutics Revenue, 2016-2021
5.2.2 By Application - China Central Nervous System Disorders Therapeutics Revenue, 2022-2027
5.2.3 By Application - China Central Nervous System Disorders Therapeutics Revenue Market Share, 2016-2027
6 Central Nervous System Disorders Therapeutics Companies Profiles
6.1 Eli Lilly
6.1.1 Eli Lilly Company Details
6.1.2 Eli Lilly Business Overview
6.1.3 Eli Lilly Central Nervous System Disorders Therapeutics Introduction
6.1.4 Eli Lilly Central Nervous System Disorders Therapeutics Revenue in China Market (2016-2021)
6.1.5 Eli Lilly Recent Developments
6.2 GlaxoSmithKline
6.2.1 GlaxoSmithKline Company Details
6.2.2 GlaxoSmithKline Business Overview
6.2.3 GlaxoSmithKline Central Nervous System Disorders Therapeutics Introduction
6.2.4 GlaxoSmithKline Central Nervous System Disorders Therapeutics Revenue in China Market (2016-2021)
6.2.5 GlaxoSmithKline Recent Developments
6.3 Janssen Pharmaceuticals
6.3.1 Janssen Pharmaceuticals Company Details
6.3.2 Janssen Pharmaceuticals Business Overview
6.3.3 Janssen Pharmaceuticals Central Nervous System Disorders Therapeutics Introduction
6.3.4 Janssen Pharmaceuticals Central Nervous System Disorders Therapeutics Revenue in China Market (2016-2021)
6.3.5 Janssen Pharmaceuticals Recent Developments
6.4 Novartis
6.4.1 Novartis Company Details
6.4.2 Novartis Business Overview
6.4.3 Novartis Central Nervous System Disorders Therapeutics Introduction
6.4.4 Novartis Central Nervous System Disorders Therapeutics Revenue in China Market (2016-2021)
6.4.5 Novartis Recent Developments
6.5 Pfizer
6.5.1 Pfizer Company Details
6.5.2 Pfizer Business Overview
6.5.3 Pfizer Central Nervous System Disorders Therapeutics Introduction
6.5.4 Pfizer Central Nervous System Disorders Therapeutics Revenue in China Market (2016-2021)
6.5.5 Pfizer Recent Developments
7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer
List of Tables
Table 1. Central Nervous System Disorders Therapeutics Market Opportunities & Trends in China Market
Table 2. Central Nervous System Disorders Therapeutics Market Drivers in China Market
Table 3. Central Nervous System Disorders Therapeutics Market Restraints in China Market
Table 4. Key Players of Central Nervous System Disorders Therapeutics in China Market
Table 5. Top Central Nervous System Disorders Therapeutics Players in China Market, Ranking by Revenue (2019)
Table 6. China Central Nervous System Disorders Therapeutics Revenue by Companies, (US$, Mn), 2016-2021
Table 7. China Central Nervous System Disorders Therapeutics Revenue Share by Companies, 2016-2021
Table 8. Companies Central Nervous System Disorders Therapeutics Product Type
Table 9. List of Tier 1 Central Nervous System Disorders Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Central Nervous System Disorders Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - China Central Nervous System Disorders Therapeutics Revenue, (US$, Mn), 2021 & 2027
Table 12. By Type - China Central Nervous System Disorders Therapeutics Revenue (US$, Mn), 2016-2021
Table 13. By Type - China Central Nervous System Disorders Therapeutics Revenue (US$, Mn), 2022-2027
Table 14. By Application - China Central Nervous System Disorders Therapeutics Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - China Central Nervous System Disorders Therapeutics Revenue (US$, Mn), 2016-2021
Table 16. By Application - China Central Nervous System Disorders Therapeutics Revenue (US$, Mn), 2022-2027
Table 17. Eli Lilly Company Details
Table 18. Eli Lilly Business Overview
Table 19. Eli Lilly Central Nervous System Disorders Therapeutics Product
Table 20. Eli Lilly Central Nervous System Disorders Therapeutics Revenue in China Market (2016-2021) & (US$ Million)
Table 21. Eli Lilly Recent Developments
Table 22. GlaxoSmithKline Company Details
Table 23. GlaxoSmithKline Business Overview
Table 24. GlaxoSmithKline Central Nervous System Disorders Therapeutics Product
Table 25. GlaxoSmithKline Central Nervous System Disorders Therapeutics Revenue in China Market (2016-2021) & (US$ Million)
Table 26. GlaxoSmithKline Recent Developments
Table 27. Janssen Pharmaceuticals Company Details
Table 28. Janssen Pharmaceuticals Business Overview
Table 29. Janssen Pharmaceuticals Central Nervous System Disorders Therapeutics Product
Table 30. Janssen Pharmaceuticals Central Nervous System Disorders Therapeutics Revenue in China Market (2016-2021) & (US$ Million)
Table 31. Janssen Pharmaceuticals Recent Developments
Table 32. Novartis Company Details
Table 33. Novartis Business Overview
Table 34. Novartis Central Nervous System Disorders Therapeutics Product
Table 35. Novartis Central Nervous System Disorders Therapeutics Revenue in China Market (2016-2021) & (US$ Million)
Table 36. Novartis Recent Developments
Table 37. Pfizer Company Details
Table 38. Pfizer Business Overview
Table 39. Pfizer Central Nervous System Disorders Therapeutics Product
Table 40. Pfizer Central Nervous System Disorders Therapeutics Revenue in China Market (2016-2021) & (US$ Million)
Table 41. Pfizer Recent Developments
List of Figures
Figure 1. Central Nervous System Disorders Therapeutics Segment by Type
Figure 2. Central Nervous System Disorders Therapeutics Segment by Application
Figure 3. China Central Nervous System Disorders Therapeutics Market Overview: 2020
Figure 4. China Central Nervous System Disorders Therapeutics Market Size: 2021 VS 2027 (US$, Mn)
Figure 5. China Central Nervous System Disorders Therapeutics Revenue, 2016-2027 (US$, Mn)
Figure 6. The Top 3 and 5 Players Market Share by Central Nervous System Disorders Therapeutics Revenue in 2020
Figure 7. By Type - China Central Nervous System Disorders Therapeutics Revenue Market Share, 2016-2027
Figure 8. By Application - China Central Nervous System Disorders Therapeutics Revenue Market Share, 2016-2027
Figure 9. Eli Lilly Central Nervous System Disorders Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 10. GlaxoSmithKline Central Nervous System Disorders Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 11. Janssen Pharmaceuticals Central Nervous System Disorders Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 12. Novartis Central Nervous System Disorders Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 13. Pfizer Central Nervous System Disorders Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
  • Global CNS Therapeutics Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 03-Oct-2023        Price: US 3380 Onwards        Pages: 101
    Market Overview of Global CNS Therapeutics market: According to our latest research, the global CNS Therapeutics market looks promising in the next 5 years. As of 2022, the global CNS Therapeutics market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Central nervous system (CNS) disease is a widespread condition in which the brain does not function properly, limiting health and function. The......
  • Global CNS Therapeutics Market Insights, Forecast to 2029
    Published: 11-Aug-2023        Price: US 4900 Onwards        Pages: 117
    Central nervous system (CNS) disease is a broad category of conditions in which the brain does not function as it should, limiting health and the ability to function. The condition may be an inherited metabolic disorder; the result of damage from an infection, a degenerative condition, stroke, a brain tumor or other problem; or arise from unknown or multiple factors. Movement disorders such as Parkinson's disease, dystonia, and essential tremor are central nervous system conditions. What they ha......
  • Central Nervous System Disorders Therapeutics Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application
    Published: 18-Apr-2023        Price: US 3500 Onwards        Pages: 131
    This report describes the global market size of Central Nervous System Disorders Therapeutics from 2018 to 2022 and its CAGR from 2018 to 2022, and also forecasts its market size to the end of 2028 and its CAGR from 2023 to 2028. For geography segment, regional supply, demand, major players, price is presented from 2018 to 2028. This report cover following regions: North America South America Asia & Pacific Europe MEA The key countries for ......
  • Global CNS Therapeutics Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 16-Mar-2023        Price: US 3260 Onwards        Pages: 117
    Central nervous system (CNS) disease is a broad category of conditions in which the brain does not function as it should, limiting health and the ability to function. The condition may be an inherited metabolic disorder; the result of damage from an infection, a degenerative condition, stroke, a brain tumor or other problem; or arise from unknown or multiple factors. Movement disorders such as Parkinson's disease, dystonia, and essential tremor are central nervous system conditions. What they ha......
  • Global CNS Therapeutics Market Research Report 2023
    Published: 06-Feb-2023        Price: US 2900 Onwards        Pages: 103
    Central nervous system (CNS) disease is a broad category of conditions in which the brain does not function as it should, limiting health and the ability to function. The condition may be an inherited metabolic disorder; the result of damage from an infection, a degenerative condition, stroke, a brain tumor or other problem; or arise from unknown or multiple factors. Movement disorders such as Parkinson's disease, dystonia, and essential tremor are central nervous system conditions. What they ha......
  • CNS Therapeutics Market, Global Outlook and Forecast 2023-2029
    Published: 03-Feb-2023        Price: US 3250 Onwards        Pages: 100
    Central nervous system (CNS) disease is a broad category of conditions in which the brain does not function as it should, limiting health and the ability to function. The condition may be an inherited metabolic disorder; the result of damage from an infection, a degenerative condition, stroke, a brain tumor or other problem; or arise from unknown or multiple factors. Movement disorders such as Parkinson's disease, dystonia, and essential tremor are central nervous system conditions. What they ha......
  • Global Central Nervous System Disorders Therapeutics Market Growth (Status and Outlook) 2023-2029
    Published: 02-Feb-2023        Price: US 3660 Onwards        Pages: 88
    Central Nervous System (CNS) disorders are also called as neurological and psychiatric disorders. CNS disorders can affect either the brain or spinal cord, or both. LPI (LP Information)' newest research report, the "Central Nervous System Disorders Therapeutics Industry Forecast" looks at past sales and reviews total world Central Nervous System Disorders Therapeutics sales in 2022, providing a comprehensive analysis by region and market sector of projected Central Nervous System Disorder......
  • Global Central Nervous System Disorders Therapeutics Market Research Report 2023
    Published: 31-Jan-2023        Price: US 2900 Onwards        Pages: 84
    Central Nervous System (CNS) disorders are also called as neurological and psychiatric disorders. CNS disorders can affect either the brain or spinal cord, or both. Highlights The global Central Nervous System Disorders Therapeutics market was valued at US$ 134580 million in 2022 and is anticipated to reach US$ 169200 million by 2029, witnessing a CAGR of 3.9% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating......
  • Central Nervous System Disorders Therapeutics Market, Global Outlook and Forecast 2023-2029
    Published: 31-Jan-2023        Price: US 3250 Onwards        Pages: 69
    Central Nervous System (CNS) disorders are also called as neurological and psychiatric disorders. CNS disorders can affect either the brain or spinal cord, or both. This report aims to provide a comprehensive presentation of the global market for Central Nervous System Disorders Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and ma......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs